3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Lung Neoplasms
3
Colorectal Neoplasms
3
Oropharyngeal Neoplasms
2
Neoplastic Cells, Circulating
2
Cholangiocarcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Recurrence
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm, Residual
1
Hematopoietic and Lymphoid System Neoplasm
1
Gallbladder Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Carcinoma, Lobular
1
Carcinoma, Hepatocellular
1
Interventions
Radiotherapy
4
osimertinib
3
aflutinib
3
Radiosurgery
3
Pemetrexed
3
Drug Therapy
3
Carboplatin
3
toripalimab
2
pembrolizumab
2
Docetaxel
2
tislelizumab
1
sugemalimab
1
lenvatinib
1
cemiplimab
1
brigatinib
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Surgical Procedures, Operative
1
S 1 (combination)
1
Platinum Compounds
1
Platinum
1
Pharmaceutical Preparations
1
Paclitaxel
1
Neoadjuvant Therapy
1
JDQ443
1
Immune Checkpoint Inhibitors
1
HM781-36B
1
Gemcitabine
1
Diphenhydramine
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
NSCLC
×
Liquid Biopsy
×
1 year
×
Clear all
No trials found.